A detailed history of Cordasco Financial Network transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Cordasco Financial Network holds 4,329 shares of GILD stock, worth $388,571. This represents 0.19% of its overall portfolio holdings.

Number of Shares
4,329
Previous 3,482 24.33%
Holding current value
$388,571
Previous $207,000 29.47%
% of portfolio
0.19%
Previous 0.13%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 15, 2022

BUY
$57.72 - $65.01 $48,888 - $55,063
847 Added 24.33%
4,329 $268,000
Q1 2022

Apr 21, 2022

SELL
$57.92 - $72.58 $18,939 - $23,733
-327 Reduced 8.58%
3,482 $207,000
Q4 2021

Jan 24, 2022

SELL
$64.88 - $73.64 $16,674 - $18,925
-257 Reduced 6.32%
3,809 $277,000
Q3 2021

Nov 12, 2021

BUY
$67.69 - $73.03 $25,925 - $27,970
383 Added 10.4%
4,066 $284,000
Q2 2021

Jul 29, 2021

SELL
$63.47 - $69.35 $17,708 - $19,348
-279 Reduced 7.04%
3,683 $254,000
Q1 2021

Apr 12, 2021

BUY
$60.0 - $68.46 $4,020 - $4,586
67 Added 1.72%
3,962 $256,000
Q4 2020

Jan 26, 2021

SELL
$56.65 - $64.55 $21,470 - $24,464
-379 Reduced 8.87%
3,895 $227,000
Q3 2020

Oct 13, 2020

SELL
$62.1 - $78.08 $15,649 - $19,676
-252 Reduced 5.57%
4,274 $270,000
Q2 2020

Jul 13, 2020

BUY
$72.34 - $84.0 $42,608 - $49,476
589 Added 14.96%
4,526 $348,000
Q1 2020

Apr 24, 2020

BUY
$62.63 - $80.22 $240,311 - $307,804
3,837 Added 3837.0%
3,937 $294,000
Q4 2019

Jan 22, 2020

SELL
$61.62 - $67.78 $8,441 - $9,285
-137 Reduced 57.81%
100 $6,000
Q3 2019

Oct 17, 2019

BUY
$62.51 - $69.0 $62 - $69
1 Added 0.42%
237 $15,000
Q2 2019

Jul 10, 2019

SELL
$61.87 - $69.38 $3,588 - $4,024
-58 Reduced 19.73%
236 $16,000
Q1 2019

Apr 10, 2019

BUY
$62.53 - $70.05 $8,379 - $9,386
134 Added 83.75%
294 $19,000
Q2 2018

Jul 11, 2018

BUY
$64.88 - $75.68 $3,892 - $4,540
60 Added 60.0%
160 $11,000
Q3 2017

Oct 19, 2017

BUY
$72.11 - $85.47 $7,211 - $8,547
100
100 $8,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $113B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Cordasco Financial Network Portfolio

Follow Cordasco Financial Network and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cordasco Financial Network, based on Form 13F filings with the SEC.

News

Stay updated on Cordasco Financial Network with notifications on news.